S
Syndax Pharmaceuticals, Inc.
SNDX · NASDAQ · Healthcare · 1.8B
Closing price
$16.99
+0.53% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
22.8×
Enterprise value / EBITDAEV/EBITDA
-6.7×
Free cash flow yieldFCF yield
-22.0%
Return on equityROE
-441.6%
Operating margin
-158.4%
Net debt / EBITDAbalance-sheet strength
-0.8×
Interest coverage
-8.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.